Abstract:Our study demonstrate that BMAL1 plays a critical role in cell migration and invasion of CRC cells via MAPK‐c‐Myc pathway. Our results may deepen our understanding in the relationship of BMAL1 and tumorigenic phenotypes and be developed into a promised therapeutic target for the BMAL1‐overexpression CRC. Background Cancer metastasis is still a life threat to patients with colorectal cancer (CRC). Brain and muscle ARNT‐like protein 1 (BMAL1) is an important biological proteins that can regulate the behavior of cancer cells and their response to chemotherapy. However, the role of BMAL1 in the tumorigenic phenotype of CRC remains unclear. Here, we aim to investigate the functional role and mechanisms of BMAL1 in CRC. Methods The mRNA expression of BMAL1 was studied using the Cancer Genome Atlas (TCGA) databases. The protein level in clinical tissues was confirmed by immunohistochemistry (IHC). The effects of BMAL1 on the epithelial‐to‐mesenchymal transition (EMT) and proliferation of CRC cell lines (including BMAL1 overexpressed or silencing cells) were studied by Transwell, wound healing, CCK‐8 and colony formation experiments. A series of experiments were conducted to demonstrate the mechanisms of BMAL1 regulating EMT and cancer proliferation in vitro and in vivo. Results We found that BMAL1 expression was closely related to the poor prognosis of CRC. BMAL1 overexpression promoted cell proliferation and migration. Mechanistically, we found that BMAL1 may activate the epithelial‐to‐mesenchymal transition (EMT) pathway and induce the β‐catenin release further promotes the expression of oncogene c‐Myc and the migration of colorectal cells by activating MAPK pathway. However, BMAL1 silencing achieved the opposite effect. In addition, blocking MAPK‐signaling pathway with specific inhibitors of ERK1/2 and JNK can also downregulate the expressions of c‐Myc in vitro. Taken together, these results suggested that the BMAL1/ c‐Myc‐signaling pathway may regulate the metastasis of CRC through the JNK/ERK1/2 MAPK‐dependent pathway. Conclusions Our study showed that BMAL1 promotes CRC metastasis through MAPK‐c‐Myc pathway. These results deepen our understanding of the relationship between BMAL1 and tumorigenic phenotypes, which may become a promising therapeutic target for BMAL1 overexpressing CRC.

C-myc Overexpression Drives Melanoma Metastasis by Promoting Vasculogenic Mimicry Via C-Myc/snail/bax Signaling

C-Myc-induced Chemosensitization is Mediated by Suppression of Cyclin D1 Expression and Nuclear Factor-Kappa B Activity in Pancreatic Cancer Cells.

Overexpression of microtubule-associated protein-1 light chain 3 is associated with melanoma metastasis and vasculogenic mimicry.

Silence of MACC1 Decreases Cell Migration and Invasion in Human Malignant Melanoma Through Inhibiting the EMT.

A Signal Transduction Pathway From Tgf-Beta 1 To Skp2 Via Akt1 And C-Myc And Its Correlation With Progression In Human Melanoma

Zwint Facilitates Melanoma Progression by Promoting C-Myc Expression

c-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment

C-Myc Overexpression is Required for Continuous Suppression of Oncogene-Induced Senescence in Melanoma Cells

Review: proteins c-Myc and Myc-nick as potential targets for the melignant melanoma treatment

High Expression of CCR5 in Melanoma Enhances Epithelial–mesenchymal Transition and Metastasis Via TGFβ1

BMAL1 promotes colorectal cancer cell migration and invasion through ERK‐ and JNK‐dependent c‐Myc expression

c-MYC-miRNA circuitry: a central regulator of aggressive B-cell malignancies.

HDAC7/c-Myc signaling pathway promotes the proliferation and metastasis of choroidal melanoma cells

The c-Myc–LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer

Extracellular vesicles microRNA-592 of melanoma stem cells promotes metastasis through activation of MAPK/ERK signaling pathway by targeting PTPN7 in non-stemness melanoma cells

MTA 1 , an independent prognostic factor , promotes melanoma cell invasion by induction of EMT

MYC Overexpression with Its Prognostic and Clinicopathological Significance in Breast Cancer.

Target c-Myc to treat pancreatic cancer

Rangtpase: A Candidate for Myc-Mediated Cancer Progression

A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth

MUC21 controls melanoma progression via regulating SLITRK5 and hedgehog signaling pathway